Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) offer a promising cell-
based therapy for myocardial infarction. However, the presence of transitory ventricular …

Human pluripotent stem cell derived cardiomyocytes (hPSC-CMs) represent an
inexhaustible cell source for in vitro disease modeling, drug discovery and toxicity …

Background: Human pluripotent stem cell (hPSC)–derived cardiomyocytes (hPSC-CMs)
have tremendous promise for application in cardiac regeneration, but their translational …

Highlighting the importance of sex as a biological variable, we recently reported sex
differences in guinea pig in vivo electrocardiogram (ECG) measurements. However …

Background Anticancer therapies have significantly improved patient outcomes; however,
cardiac side effects from cancer therapies remain a significant challenge. Cardiotoxicity …

Cardiac optical mapping, also known as optocardiography, employs parameter-sensitive
fluorescence dye (s) to image cardiac tissue and resolve the electrical and calcium …

Introduction: Human pluripotent stem cells (hPSCs) provide many opportunities for
application in regenerative medicine due to their ability to differentiate into cells from all …

After myocardial infarction (MI), a significant portion of heart muscle is replaced with scar
tissue, progressively leading to heart failure. Human pluripotent stem cell‐derived …

Acute engraftment arrhythmias (EAs) remain a serious complication of remuscularization
therapy. Preliminary evidence suggests that a focal source underlies these EAs stemming …

No area of congenital heart disease has undergone greater change and innovation than
single ventricle management over the past 20 years. Surgical and catheterisation laboratory …